Rigel Pharmaceuticals
RIGL
17,25 €
Share price
-0.89%
Change (1 day)
75.86%
Change (1 year)
Categories
Market capitalization of Rigel Pharmaceuticals (RIGL)
Market cap: €0.30 Billion
As of July 2025 Rigel Pharmaceuticals has a market cap of €0.30 Billion. This makes Rigel Pharmaceuticals the world's 7692th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Rigel Pharmaceuticals from 2000 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €0.30 B | 10.35% |
| 2024 | €0.27 B | 22.12% |
| 2023 | €0.22 B | -5.37% |
| 2022 | €0.24 B | -39.6% |
| 2021 | €0.40 B | -16.78% |
| 2020 | €0.48 B | 49.84% |
| 2019 | €0.32 B | -4.52% |
| 2018 | €0.33 B | -29.05% |
| 2017 | €0.47 B | 111.61% |
| 2016 | €0.22 B | -10.79% |
| 2015 | €0.25 B | 52.71% |
| 2014 | €0.16 B | -9.02% |
| 2013 | €0.18 B | -57.82% |
| 2012 | €0.42 B | -1.07% |
| 2011 | €0.43 B | 46.27% |
| 2010 | €0.29 B | -14.2% |
| 2009 | €0.34 B | 64.73% |
| 2008 | €0.20 B | -61.64% |
| 2007 | €0.54 B | 140.9% |
| 2006 | €0.22 B | 29.35% |
| 2005 | €0.17 B | -50.52% |
| 2004 | €0.35 B | 56.52% |
| 2003 | €0.22 B | 369.8% |
| 2002 | €48.13 M | -75.77% |
| 2001 | €0.19 B | -49.15% |
| 2000 | €0.39 B |
End of Day market cap according to different sources
On Jul 28th, 2025 the market cap of Rigel Pharmaceuticals was reported to be:
€0.30 Billion
€0.30 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ChemoCentryx CCXI | €3.22 B | 946.58% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | €0.12 B | -58.79% | 🇺🇸 USA |
 AstraZeneca AZN | €195.79 B | 63,425.06% | 🇬🇧 UK |
 Amgen AMGN | €139.76 B | 45,245.47% | 🇺🇸 USA |